Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-001324
Filing Date
2021-02-02
Accepted
2021-02-02 17:30:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27674
2 filename2.txt TEXT-EXTRACT 1500
  Complete submission text file 0000000000-21-001324.txt   40315
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filed for) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations